» Articles » PMID: 37816820

The ATF2/miR-3913-5p/CREB5 Axis is Involved in the Cell Proliferation and Metastasis of Colorectal Cancer

Abstract

Various miRNAs have been shown to participate in the tumor progression and development of colorectal cancer (CRC). However, the role of miR-3913-5p in CRC are yet to be clearly defined. In the present study, we determine that miR-3913-5p is downregulated in CRC cell lines and CRC tissues. Exogenous miR-3913-5p expression weakens the CRC cells growth, migration and invasion. Mechanistically, miR-3913-5p directly targets the 3'UTR of CREB5. Overexpression of CREB5 reverses the suppression of CRC cells proliferation, migration and invasion induced by miR-3913-5p. Furthermore, ATF2 negatively regulates the transcription of miR-3913-5p by binding to its promoter. CREB5 can cooperate with ATF2. CREB5 is required for ATF2 in regulating miR-3913-5p. Finally, inverse correlations can be found between the expressions of miR-3913-5p and CREB5 or ATF2 in CRC tissues. Thus, a plausible mechanism of ATF2/miR-3913-5p/CREB5 axis regulating CRC progression is elucidated. Our findings suggest that miR-3913-5p functions as a tumor suppressor in CRC. ATF2/miR-3913-5p/CREB5 axis might be a potential therapeutic target against CRC progression.

Citing Articles

Up-regulation of mA writer METTL14 inhibits tumorigenesis by suppressing glycolysis in colorectal cancer.

Li L, Zhang R, Li Y BMC Cancer. 2025; 25(1):305.

PMID: 39979838 PMC: 11844156. DOI: 10.1186/s12885-025-13532-2.


Identification of key genes to predict response to chemoradiotherapy and prognosis in esophageal squamous cell carcinoma.

Cui Y, Wen J, Fu J, Leng C Front Mol Biosci. 2024; 11:1512715.

PMID: 39633985 PMC: 11614722. DOI: 10.3389/fmolb.2024.1512715.

References
1.
Watson G, Ronai Z, Lau E . ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease. Pharmacol Res. 2017; 119:347-357. PMC: 5457671. DOI: 10.1016/j.phrs.2017.02.004. View

2.
Li X, Chen C, Wang Z, Liu J, Sun W, Shen K . Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer. Cancer Cell Int. 2021; 21(1):428. PMC: 8364701. DOI: 10.1186/s12935-021-02075-8. View

3.
Huebner K, Erlenbach-Wuensch K, Prochazka J, Sheraj I, Hampel C, Mrazkova B . ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2. Cell Mol Life Sci. 2022; 79(8):423. PMC: 9287261. DOI: 10.1007/s00018-022-04445-5. View

4.
Liu X, Chen J, Zhang S, Liu X, Long X, Lan J . LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1. EMBO Rep. 2022; 23(9):e54128. PMC: 9442307. DOI: 10.15252/embr.202154128. View

5.
Contreras-Sanzon E, Palma-Flores C, Flores-Perez A, Salinas-Vera Y, Silva-Cazares M, Marchat L . MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells. Cancer Biomark. 2022; 35(1):47-56. DOI: 10.3233/CBM-210457. View